ReviewTranslational lung cancer research2021

How to optimize the incorporation of immunotherapy in trials for oligometastatic non-small cell lung cancer: a narrative review.

Jordi Remon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.